{"brief_title": "A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension", "brief_summary": "The primary objective of this study is to compare the safety and efficacy of Brimonidine Tartrate Ophthalmic Solution, 0.15% in patients with open-angle glaucoma or ocular hypertension.", "condition": ["Open-Angle Glaucoma", "Ocular Hypertension"], "intervention_type": ["Drug"], "intervention_name": ["Brimonidine Tartrate Ophthalmic Solution"], "criteria": "- Patients of any race - two (2) years of age or older - of either sex - diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)or ocular hypertension", "gender": "All", "minimum_age": "2 Months", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Ocular Hypertension", "mesh_term": ["Hypertension", "Glaucoma", "Glaucoma, Open-Angle", "Ocular Hypertension", "Pharmaceutical Solutions", "Brimonidine Tartrate", "Ophthalmic Solutions"], "id": "NCT00061529"}